Ceftobiprole medocaril

Zevtera

500 MG / VIAL Powder For SolutionCanadaMarketedAuthorised 20 Mar 2018

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

ZevteraBrazil · United Medical LtdaSame brand
Zevtera 500 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 666.6 mg · polvo para concentrado para solución para perfusión · Advanz Pharma LimitedSame brand
ZEVTERA 500 mg Powder for concentration for Solution for InfusionSaudi Arabia · Nipro Pharma Corporation Ise PlantSame brand
ZevteraUnited States · 667MG/VIAL · powder · IstxSame brand
Zeftera (previously Zevtera)European Union · Janssen-Cilag International NVSame substance
MabelioItaly · Polvere per concentrato per soluzione per infusione · Advanz Pharma LimitedSame substance

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Ceftobiprole medocaril

Zevtera

500 MG / VIAL Powder For SolutionCanadaMarketedAuthorised 20 Mar 2018

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Ceftobiprole medocaril
Strength: 500 MG / VIAL
Dosage form: Powder For Solution
Route: Intravenous
Register: Canada (Health Canada)
Status: Marketed
Authorised: 20 Mar 2018
Registration: DIN 02446685
Marketing authorisation holder: Avir Pharma INC.
ATC code: J01DI01
Group: Anti-infectives for systemic use
Supply: PRESCRIPTION